Sign in

Trial result ·

Indirect moxibustion therapy improves insomnia and associated symptoms in patients with schizophrenia.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This was a randomized trial in 120 people with schizophrenia and poor sleep. All people took low-dose dexzopiclone. One group got real moxibustion and one got a sham version. The groups had 60 people each. The treatment lasted 8 weeks. The trial ran at one center in Shanghai. It looked at sleep quality and quality of life.

What they found

At baseline the groups had similar scores. After 4 and 8 weeks, the real treatment group had lower sleep and quality-of-life scores. At week 4 the sleep scores were 10.10 and 13.50. At week 8 they were 10.65 and 12.77. Changes from baseline were larger in the real treatment group. All differences were statistically significant.

What it means for patients

The authors say add-on moxibustion led to better sleep and quality of life than sham. They call the findings preliminary. They see it as a possible add-on therapy.

Why it is not certain yet

The authors call these findings preliminary. This was one center. The trial lasted 8 weeks. They say multicenter, longer trials with more outcomes are needed. The abstract does not say if the gains last.

Source

Indirect moxibustion therapy improves insomnia and associated symptoms in patients with schizophrenia.

PubMed · PMID 42928360

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Insomnia publications